HQY Form 4: Founder Neeleman Sells 1,058 Shares, Retains 753K Indirect
Rhea-AI Filing Summary
Stephen Neeleman, Founder and Vice Chairman of HealthEquity, Inc. (HQY), reported changes in his beneficial ownership on 10/06/2025. He disposed of 1,058 shares of common stock at a price of $88.5674 per share, reducing his direct holdings to 111,535 shares. The sale is recorded under transaction code F (a disposition).
The filing also shows substantial indirect ownership: 550,235 shares held of record by the Stephen and Christine Neeleman Trust and 203,000 shares held by Neeleman Family Holdings, LLC, for which he is the manager. Mr. Neeleman continues to hold stock options exercisable for 19,897, 14,228, and 15,337 shares with exercise prices of $41.28, $61.72, and $73.61 respectively; the $41.28 option is immediately exercisable.
Positive
- Retained large indirect ownership of 550,235 and 203,000 shares, indicating continued alignment with shareholder interests
- Outstanding options have exercise prices ($41.28, $61.72, $73.61) below the reported sale price ($88.5674), suggesting potential economic upside if market price remains
Negative
- Direct sale of 1,058 shares at $88.5674 reduced direct holdings to 111,535 shares
- Disposition recorded (code F) could precede further sales; a pattern of dispositions would be negative if repeated
Insights
Insider sold a small portion of direct holdings while retaining large indirect and option positions.
The reported disposition of 1,058 shares reduces direct ownership to 111,535 shares, but substantial indirect holdings of 550,235 and 203,000 shares remain under trust and family entities. Such filings often reflect routine liquidity needs or portfolio rebalancing rather than a change in control given the large retained stake.
Key dependencies include whether additional sales occur and the exercisability timeline for options, particularly the immediately exercisable option for 19,897 shares. Monitor subsequent Section 16 filings for any pattern of sales over the next weeks.
Small sale at $88.5674 per share amid large option grants with lower strike prices.
The sale price of $88.5674 is above the listed option exercise prices of $41.28, $61.72, and $73.61, which means exercising options could be economically attractive if market price remains similar. The filing notes one option is immediately exercisable, creating flexibility for future transactions.
Risks include potential future sales that could signal changing insider sentiment; look for additional Form 4s or aggregate sales over the next quarter to assess materiality.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 1,058 | $88.5674 | $94K |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Shares held of record by the Stephen and Christine Neeleman Trust. Shares held of record by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes. The option is immediately exercisable.
